48 results for "Francesco Perrone"
Showing 1–20 · 0.37 seconds · RSS
-
Journal Article
FINANCIAL TOXICITY: AN EMERGING PROBLEM FOR CANCER PATIENTS
Financial toxicity is one of the emerging problems in the management of cancer patients, mainly in countries characterized by a private health system and in those defned as low-middle income countries (LMIC). However, data published in 2016 have shown that it is also a problem in Italy.
-
Journal Article
Planning and allocating resources for pharmaceuticals to health care organisations: a proposal from the Regional Pharmaceutical Policies Forum
Introduction: This document illustrates the results of a multi-disciplinary and multi-stakeholder Working Group (WG), focused on planning and allocation of resources for pharmaceuticals from the Regions to the Health Authorities. The WG was carried out during the Fourth Edition of the Regional…
-
Journal Article
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan
Background: Tocilizumab, an IL-6 receptor antagonist, was suggested as a possible treatment of severe or critical COVID-19 pneumonia in a small Chinese study. The TOCIVID-19 trial evaluates efficacy and tolerability of tocilizumab in the treatment of patients with severe or critical COVID-19…
-
Journal Article Full text
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
Randomized clinical trials are considered the milestones of clinical research in oncology, and guided the development and approval of new compounds so far. In the last few years, however, molecular and genomic profiling led to a change of paradigm in therapeutic algorithms of many cancer types…
-
Journal Article Full text
The Other Side of the Same Coin: Beyond the Coding Region in Amyotrophic Lateral Sclerosis
Transposable elements (TEs), once regarded as genomic “junk,” are now recognized as powerful regulators of gene expression, genome stability, and innate immunity. In the context of neurodegeneration, particularly Amyotrophic Lateral Sclerosis (ALS), accumulating evidence implicates TEs as active…
-
Journal Article
The opportunity of patient-journey studies for academic clinical research in oncology
A wave of new treatments and treatment combinations are becoming available for solid tumours. Trials performed to obtain registration establish a positive benefit-risk but unavoidably leave many questions unanswered on place-in-therapy and the relative efficacy of different treatment sequences…
-
Journal Article Full text
Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral Sclerosis-Related Cellular Deficits
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease for which there is currently no cure. Dominant mutations in the TARDBP gene are causative of ALS. In particular, the p. G376D substitution in TDP-43 causes familial ALS and it is associated with TDP-43 mislocalization in the…
-
Journal Article
Designing, producing and exemplifying videos to support reflection and metacognition for in-service teachers training
In this paper we document a six-phase video production process designed to support teachers’ continuous professional development in three disciplinary areas: scientific, linguistic-literary and foreign languages areas. This production has been carried out within the NOP1 - National Operational…
-
Journal Article Full text
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
Background: The European Association for the Study of the Liver (EASL) criteria and the modified Response Evaluation Criteria in Solid Tumors (mRECIST) are currently adopted to evaluate radiological response in patients affected by HCC and treated with loco-regional procedures. Several studies…
Also available at: DOAJ
-
Journal Article
The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review
Background: Standard of Care (SoC) has been used with different significance across Randomized Clinical Trials (RCTs) on the treatment of Covid-19. In the context of a living systematic review on pharmacological interventions for COVID-19, we assessed the characteristics of the SoC adopted in the…
-
Journal Article
Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy
Objective To investigate whether the prices of new anticancer drugs correlated with their relative benefit despite negotiation.Design Retrospective cross-sectional study correlating new anticancer drugs prices with clinical outcomes.Setting We did a retrospective cross-sectional study including all…
-
Journal Article
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Abstract The great debate session at the 2018 Melanoma Bridge congress (November 29–December 1, Naples, Italy) featured counterpoint views from experts on three topical issues in melanoma. These were whether overall survival should still be the main endpoint for clinical trials in melanoma, whether…
-
Journal Article
The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020
Abstract As part of the 2020 Immunotherapy Bridge virtual congress (December 2nd–3rd, Italy), the Great Debate session featured counterpoint views from leading experts on three clinical questions in immunotherapy today. The first of these was whether antitumoral vaccination is still a treatment…
-
Journal Article
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy
Objectives. Serum cystatin C seems to be an accurate marker of glomerular filtration rate (GFR) compared to serum creatinine. The aim of this work was to explore the possibility of using serum cystatin C instead of serum creatinine to early predict renal failure in cancer patients who received…
-
Journal Article Full text
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
Patients with cancer frequently experience symptoms related to their disease or treatment-related toxicities. Symptom management through optimal supportive care is a foundation of quality care. While objective toxicities and laboratory results are amenable to reporting by health care personnel…
-
Journal Article Full text
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
Aim: The aim of the present study was to assess the estimated “per patient” total cost for a single Oncologic Italian Cancer Center participating in a multicenter clinical trial with new anticancer biological agents using the activity-based costing (ABC) methodology. Methodology: Nine randomized…
-
Journal Article
Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments
Abstract Background Characteristics of patients significantly differ between registrational clinical trials (CTs) and Italian real-world practice, with older median age, higher elderly (≥ 65) rate and worse performance status (PS) in the latter, without imbalance in female rate. We compared the…
-
Journal Article Full text
Time Spent for Activation of Non-Profit Studies in Oncology in Italy
Aim: The aim of this paper is to describe the time spent to activate oncological non-profit clinical trials promoted in Italy by the National Cancer Institute of Naples, following the implementation of recent European laws. Methodology: Data about the process of activation of 5 non-profit…